A New BioPharma Intelligence Resource Set to Give Industry Leaders the Edge

OXFORD, England, October 21, 2010 - In the current BioPharma economic climate; with smaller
companies desperately needing the right development partners for survival and
larger ones needing to support their existing businesses through making the
right deals, having the best, most comprehensive, intelligence and insights
are absolutely essential for success.

It is into this environment that PharmaTelevision Ltd (a
subsidiary of PharmaVentures Ltd), announced today the launch of
PharmaDeals(R) v4, the world's first online, multimedia, dedicated
pharmaceutical industry deals intelligence resource.

Fintan Walton, PhD, Chief Executive of PharmaVentures says,
"There are huge changes taking place in the world of deal making. There are
more urgent needs for successful deals to be made and yet the resources
required are harder to access. More companies are doing specialist deals, for
example, with orphan drugs, and the world is changing as new technologies,
mechanisms of action, and even new therapy areas, emerge."

"As leading practitioners of BioPharma deal making, we have
worked diligently to develop an intelligence and insight resource that is
truly at the cutting edge in terms of its delivery to customers, while we
stay very focussed on ensuring quality of the content." Dr Walton continues,
"PharmaDeals v4 gives executives within the biopharmaceutical and related
industries, an ability to expand their understanding, deduce trends and
extract vital intelligence needed for critical decision making, forming a
significant part of the solution to help companies navigate these challenging
times."

Steve MacKenzie-Lawrie (Director of Sales at PharmaTelevision)
explains, "We took the existing PharmaDeals database and have made some truly
significant developments. We have provided deeper classifications within drug
delivery technologies and orphan drugs and following customer requests, the
scope of the PharmaDeals v4 database has been expanded to now include
categories of deals that have medical and therapeutic applications in
cosmetics, nutritional supplements, packaging, wound care and bioterrorism".

MacKenzie-Lawrie expands, "Business intelligence and BD
subscribers asked us to include share-price information, so we now have
real-time links to stock markets, including NASDAQ & LSE, providing valuable
information on the impact deals have made to the Company's share price."

Also, for the first time, the database now includes exclusive
video interviews with deal makers around the world, allowing users to watch
the major players in action and so deriving information simply not available
elsewhere. This is invaluable in helping to understand and gain further
insight into the individuals and companies involved in deal making, after all
deal making is a people business.

Dr Walton concludes, "Gaining insight into the companies' deal
making activities and the people behind the deals will help our subscribers
when they come to negotiate with these individuals across the deal table.
Watching the PharmaTelevision interviews is an informative way of doing their
due diligence on the companies they want to partner with before they enter
into negotiations. This is the icing on the cake."

About PharmaTelevision

PharmaTelevision Limited (www.pharmatelevision.com) is
based in Oxford, England and is a wholly owned subsidiary of PharmaVentures
Ltd, a leading international corporate advisory firm supporting its clients'
growth ambitions through licensing, joint ventures and M&A in the healthcare
industry (www.pharmaventures.com ). It produces the highly popular
PharmaDeals(R) (www.pharmadeals.net) range of intelligence products
including analysis tools and reports. In 2006, it launched the world's first
dedicated online pharmaceutical television channel PharmaTelevision(R)
(www.pharmatelevision.com).

PharmaDeals(R) is a registered Trade Mark of PharmaVentures
Ltd.

    For more information on PharmaDeals v4 or to request a demonstration,
    please contact the PharmaDeals v4 Team:

    E-mail: enquiries@pharmadeals.net
    Tel: +44(0)1865-332-726

For more information on PharmaDeals v4 or to request a demonstration, please contact the PharmaDeals v4 Team: E-mail: enquiries at pharmadeals.net, Tel: +44(0)1865-332-726